程序化冻融周期中雌激素剂量与持续时间对产科结局及胎盘发现的影响
该回顾性队列研究纳入2009至2017年单中心57例高剂量雌激素组与274例对照的单胎活产分娩,比较程序化冻融胚胎移植后的产科结局与胎盘发现。高剂量雌激素与较低平均出生体重、低出生体重儿、双叶胎盘、副胎盘、绒毛加速成熟、胎盘后血肿及母体灌注不良病变相关。作者认为此关联可能与子宫内膜特性改变有关而非治疗本身。
要点
- 高剂量雌激素组雌激素治疗时间、累积剂量更高,子宫内膜厚度更低。
- 校正混杂后,高剂量雌激素与较低平均出生体重及低出生体重儿风险升高相关。
- 高剂量雌激素还与双叶胎盘、副胎盘、绒毛加速成熟、胎盘后血肿及母体灌注不良病变相关。
核心结论
- 程序化冻融胚胎移植中较高每日雌激素剂量与低出生体重及胎盘改变相关,但作者认为此关联可能与子宫内膜特性改变有关而非治疗本身。
研究设计与样本
- 回顾性队列研究,纳入2009至2017年单中心单胎活产分娩,包括经体外受精程序化冻融胚胎移植获得的分娩,排除卵母细胞受者。
- 高剂量雌激素定义为整个治疗期间每日剂量>6 mg。
- 高剂量雌激素组57例分娩,对照组274例分娩。
- 所有胎盘均行评估,采用阿姆斯特丹分类分析胎盘发现。
主要发现
- 高剂量雌激素组雌激素治疗时间显著更长(18.8±4.9天 vs 13.3±2.7天,P<0.001)。
- 高剂量雌激素组总累积雌激素剂量显著更高(149.7±46.1 mg vs 80.3±16.8 mg,P<0.001)。
- 高剂量雌激素组子宫内膜厚度显著更低(8.5±1.4 mm vs 9.8±1.7 mm,P<0.001)。
- 校正混杂因素后,较高剂量雌激素与较低平均出生体重相关(系数-252.4 g,95%CI -483.5至-21.2)。
- 校正混杂因素后,较高剂量雌激素与低出生体重儿率升高相关(aOR 4.88,95%CI 1.05至22.57)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does programmed frozen embryo transfer (FET) with high-dose oestrogen affect obstetric outcomes and placental findings? DESIGN: A retrospective cohort of live singleton deliveries at a single institution between 2009 and 2017, including deliveries attained by IVF with programmed FET; oocyte recipients were excluded. High-dose oestrogen was defined as a daily dose >6 mg throughout treatment. All placentas were evaluated regardless of complication status and the Amsterdam classification was used to analyse findings. RESULTS: A total of 57 deliveries in the high-dose oestrogen group were compared with 274 controls. The high-dose oestrogen group displayed significantly longer duration of oestrogen treatment (18.8 ± 4.9 versus 13.3 ± 2.7 days, P < 0.001), total cumulative oestrogen dose (149.7 ± 46.1 versus 80.3 ± 16.8 mg, P < 0.001) and lower endometrial thickness (8.5 ± 1.4 versus 9.8 ± 1.7 mm, P < 0.001). After adjustment for confounders, higher dose oestrogen was found to be associated with a lower average birthweight (coefficient -252.4 g, 95% confidence interval [CI] -483.5 to -21.2), a higher rate of low-birthweight neonates (adjusted odds ratio [aOR] 4.88, 95% CI 1.05 to 22.57), bilobated placentas (aOR 3.36, 95% CI 1.04 to 10.89), accessory lobes (aOR 8.74, 95% CI 1.24 to 61.5), accelerated villous maturation (aOR 2.06, 95% CI 1.09 to 3.87), retroplacental haematoma (aOR 5.39, 95% CI 1.11 to 26.13) and maternal malperfusion lesions (aOR 1.46, 95% CI 1.04 to 2.05). CONCLUSION: A higher daily oestrogen dose in programmed FET is associated with low birthweight and placental changes, although this may relate to altered endometrial properties and not to the treatment itself.
引用
- Ganer Herman H, Volodarsky-Perel A, Nu TNT, et al. The effect of oestrogen dose and duration in programmed frozen cycles on obstetric outcomes and placental findings. Reprod Biomed Online. 2023. PMID: 36737275. doi:10.1016/j.rbmo.2023.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。